Search
Search Results
-
Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules
ObjectiveThis prospective observational study aimed to evaluate the efficacy of radiofrequency ablation (RFA) in treating ≤ 2 cm thyroid nodules with...
-
A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More
Significant interobserver variabilities exist for Bethesda category III: atypia of undetermined significance (AUS) of The Bethesda System for...
-
Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review
The increasing prevalence of thyroid cancer emphasizes the need for a thorough assessment of risk of malignancy in Bethesda III nodules. Various...
-
Critical Appraisal of the 2017 Bethesda System for Reporting Thyroid Cytopathology with Cytohistological Concordance and Estimation of Risk of Malignancy - An Institutional Study
AimBethesda System for reporting thyroid cytopathology established in 2009 was updated for the first time in 2017. Since its introduction very few...
-
Evaluation of Thyroid Lesions by Fine Needle Aspiration Cytology According to Bethesda System
Aim To study cytology of various Thyroid lesions based on Bethesda system and to evaluate diagnostic accuracy of cytology by comparing it with...
-
Bethesda Category III thyroid nodules: descriptive cytological aspects of a series
BackgroundThe Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is used for cytopathological diagnosis of fine needle aspiration (FNA) of...
-
NIFTP-adjusted risk estimation of Bethesda thyroid cytology categories should consider the indication for FNA according to TIRADS
BackgroundNon-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) was firstly described in 2016. Since NIFTP is thought...
-
The relationship between ultrasound-based TIRADS and BETHESDA categories in patients undergoing thyroid biopsy
The TIRADS is a scoring system used for the selection of nodules for FNA and classification of the risk of malignancy based on ultrasound...
-
The Bethesda System for Reporting Thyroid Cytopathology Definitions, Criteria, and Explanatory Notes
The previous edition of The Bethesda System for Reporting Thyroid Cytopathology provided important updates and advances in the practice of thyroid...
-
Is conservative management of the indeterminate thyroid nodule [Thy3f or Bethesda category IV] safe?
PurposeThe histological diagnosis after diagnostic thyroidectomy for indeterminate thyroid nodules is often non-malignant and some cancers detected...
-
-
Correlation of TIRADS and Bethesda Scoring Systems with Final Histopathology of Thyroid Nodules – An Institutional Experience
Fine needle aspiration cytology (FNAC) reduces the number of unnecessary thyroid surgeries for patients with benign nodules and appropriately triages...
-
Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review
BackgroundMolecular testing has been used for cytologically indeterminate thyroid nodules (Bethesda III and IV), where the risk of malignancy is...
-
Cancer prevalence in the subcategories of the indeterminate class III (AUS/FLUS) of the Bethesda system for thyroid cytology: a meta-analysis
PurposeThe indeterminate cytologic report represents a major challenge in the field of thyroid nodule. The indeterminate class III of the Bethesda...
-
Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study
PurposeMalignancy prediction in indeterminate thyroid nodules is still challenging. We prospectively evaluated whether the combination of ultrasound...
-
Usefulness of The Bethesda System of Reporting Thyroid Cytopathology in Surgical Planning
The Bethesda system for reporting thyroid cytopathology (TBSRTC) has attempted to standardize thyroid fine needle aspiration cytology (FNAC)...
-
Low reproducibility of equivocal categories of the Bethesda System for Reporting Thyroid Cytology makes the associated risk of malignancy specific to the diagnostic center
PurposeEquivocal categories (III, IV, V) of the Bethesda System for Reporting Thyroid Cytology (BSRTC) are characterized by high variability of the...
-
Validating the ‘CUT score’ risk stratification tool for indeterminate thyroid nodules using the Bethesda system for reporting thyroid cytopathology
PurposeManaging intermediate thyroid nodules remains challenging. The CUT score is an Italian metanalysis-based cytologic (SIAPEC-IAP) scoring...
-
Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria
PurposeAs few genotype–phenotype correlations are available for nonsyndromic hereditary colorectal cancer (CRC), we implemented genomic analysis on...
